Evidence that metastases arisede novoas new cancers from cells of target organs

Author:

Raghuram Gorantla V.,Pal Kavita,Shende Soniya,Khare Naveen Kumar,Jadhav Vishalkumar,Shinde Sushma,Prasad Ratnam,Wani Harshada,Mittra IndraneelORCID

Abstract

AbstractIntroductionBased on our earlier report that cell-free chromatin particles (cfChPs) released from dying cancer cells are potentially oncogenic, we hypothesised that metastases arise as new cancers from the cells of target organs transformed by cfChPs released from dying cancer cells.MethodsWe intravenously injected MDA-MB-231 human breast cancer cells and A375 human melanoma cells into mice with severe combined immunodeficiency. In separate experiments, we intravenously injected purified cfChPs isolated from radiation-killed MDA-MB-231 cells.ResultsWe observed that the injected MDA-MB-231 and A375 cells died upon reaching the lungs, and released cfChPs that accumulated in the lung cell nuclei at 48 h. We detected the activation of 10 hallmarks of cancer and immune checkpoints in lung cells at 72 h, suggesting that the lung cells had rapidly transformed into incipient cancer cells. Metaphase preparations and single-cell clones developed from cell cultures of lung metastases that subsequently developed contained chimeric chromosomes of both mouse and human DNA, and the cells co-expressed both human- and mouse-specific proteins. The Intravenously injected purified cfChPs isolated from radiation-killed MDA-MB-231 cells also induced lung metastasis containing chimeric chromosomes and co-expressing proteins.DiscussionThese results provide evidence to suggest that cfChPs released from dying cancer cells integrate into genomes of target cells to transform them into new cancers which masquerade as metastasis. They support our hypothesis that metastases arise from the cells of target organs and not from cells derived from the primary tumour. These findings have implications for therapeutic policies for cancer.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3